CD25 (IL2Rα) is regulated by STAT5 activity and increased CD25 expression is reported to reduce proliferation capacity of CML LSCs [32]. The gene discussed is IL2RA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.